ABSTRACT

Background: Cancer is annually responsible for millions of deaths in Europe and billions of euros in productivity losses; the estimated mortality rate of lymphoma was of 7.07 per 100,000 individuals in Spain in 2018. This study aimed to evaluate the burden that lymphoma mortality represents for the Spanish society.

Methods: The human capital approach was used to estimate the costs derived from premature mortality due to lymphoma between 2008 and 2017.

Results: The number of deaths attributable to lymphoma increased steadily over the study period; the major number of deaths occurred among males aged 80 to 84 years. During the study period, 97,069 years of productive life were lost, a parameter that decreased noticeably over time due to the reduction in the number of deaths at working age. Productivity losses decreased accordingly. Lymphoma represented the 45.36% of losses due to hematological malignancies, generating €121 million in losses the year 2017. Hodgkin lymphoma was, among hematological malignancies, the malignancy accounting for the highest portion of losses per individual.

Conclusions: Lymphoma represents a significant burden that can be reduced with the implementation of improved diagnosis and treatment methods, which must be taken into account in resource allocation and management policies.

摘要

背景：癌症每年在欧洲造成数百万人死亡，数十亿欧元的生产力损失。据估计，2018年西班牙的淋巴瘤死亡率为每10万人中7.07例。这项研究旨在评估淋巴瘤死亡率对西班牙社会造成的负担。

方法：采用人力资本方法估算2008年至2017年间因淋巴瘤导致的过早死亡而产生的费用。

结果：在研究期间，归因于淋巴瘤的死亡人数稳步上升；死亡人数最多的是80至84岁的男性。在研究期间，失去了97,069年的生产寿命，该参数随着工作时间死亡人数的减少而随着时间的推移而显着下降。生产力损失相应减少。淋巴瘤占血液系统恶性肿瘤损失的45.36％，2017年产生了1.21亿欧元的损失。霍奇金淋巴瘤是血液系统恶性肿瘤中每人损失最大的部分。

结论：淋巴瘤是一个重大负担，可以通过实施改进的诊断和治疗方法来减轻，这在资源分配和管理政策中必须予以考虑。